Premier Alternatives

Clasp Therapeutics

Rockville, MD · Founded 2020 · Privately Held (backing)

Developer of a precision oncology platform designed to support the development of targeted therapies for hard-to-treat cancers. Clasp Therapeutics is based in Rockville, MD and was founded in 2020. Its last reported valuation was $192 million in Dec 2023. It has raised $150 million.

Last reported valuation
$191.5M
Oct 2026
Priced at
—
Total raised
$150.0M
Last round
—

Clasp Therapeutics key facts

as of Oct 2026
  • Developer of a precision oncology platform designed to support the development of targeted therapies for hard-to-treat cancers.
  • Clasp Therapeutics is valued at approximately $191.5M as of Oct 2026 (last reported valuation).
  • It has raised $150.0M; the latest was Later Stage VC in Jan 2025.
  • Notable investors include Alexandria Venture Investments, Novo Holdings, Catalio Capital Management, Spur Capital Partners, Vivo Capital — 16 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$191.5M

Clasp Therapeutics's last reported valuation, Dec 2023. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Clasp Therapeutics with a free account
  • ·The complete investor list: 16 names
  • ·Watch Clasp Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Clasp Therapeutics funding rounds

No rounds on record

No funding rounds for Clasp Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Clasp Therapeutics valuation

Clasp Therapeutics's last reported valuation was $192 million in Dec 2023. No priced round, secondary trade or fund mark has surfaced since.

Clasp Therapeutics investors

16 investors are on record for Clasp Therapeutics, including Alexandria Venture Investments, Novo Holdings, Catalio Capital Management and Spur Capital Partners. By type, the record holds 4 venture capital firms and 1 private equity firm.

About Clasp Therapeutics

Developer of a precision oncology platform designed to support the development of targeted therapies for hard-to-treat cancers. The company's platform identifies tumor-specific neoantigens from oncogenic driver mutations and creates agents that selectively bind to HLA-presented peptides, enabling clinical-stage immuno-oncology firms to develop therapeutics that precisely target and destroy cancer cells across multiple tumor types.

Sector
Healthcare
HQ
Rockville, MD, United States
Founded
2020
Employees
50
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.